Market, according to Future Market Insights, is entering a stable growth phase, driven by rising hospital demand for faster ...
Five sites recruiting in US study of DLL3-targeting 212Pb-labelled Radio-DARPin MP0712 Dosing ongoing in first patients, consecutively moving to subsequent dosing cyclesInitial data anticipated within ...
The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is entering a stable growth phase, driven by rising hospital ...
Phase 2 is expected to be more complex than Phase 1, as cleanup crews deal with a part of the building that is structurally ...
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States. FDA agrees with the clinical protocol and proposed statistical framework across three standard ...
Shares in the AI-enabled heart imager have vaulted up to 50%, on the back of a $10-20 million investment from radiology giant ...
A depth-compensated diffractive optical element photoacoustic microscope enables more uniform photoacoustic imaging across tissue depths.
Key findings presented at EAN 2026: In the subset of patients with neurologic symptoms at baseline from the 2:1 randomized Phase 3 FoCus clinical trial (NCT03403205; n=207), ALXN1840 demonstrated ...
Copenhagen, Denmark, 29 June 2026 - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today announced positive results fro ...
IBX announced that it has secured firm commitments for AU$3.75M (US$2.59M) in new capital following the FDA’s clearance of ...
Nearly 100 years ago, a seemingly simple discovery revolutionized the microscope. The introduction of phase contrast, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results